46 results on '"Hampel H"'
Search Results
2. EE139 Using a User-Friendly Modeling Tool to Inform and Guide Local Decision-Making for Lynch Syndrome Screening at Healthcare Systems
3. PCN39 Economic Evaluation of Universal Lynch Syndrome Screening Protocols Among Newly Diagnosed Patients with Colorectal Cancer
4. Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosis
5. Universal germline screening for Lynch syndrome in endometrial cancer
6. Concordance of germline multigene panel testing with prior microsatellite instability and immunohistochemistry analyses in endometrial cancer patients
7. A single institution pilot study for universal Lynch syndrome screening: A key step towards statewide screening and care
8. MSH6 and PMS2 Mutation Carriers Ascertained Through Multi-gene Panel Testing May Present With a Hereditary Breast and Ovarian Cancer Phenotype
9. Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease
10. Paths to Alzheimer's disease prevention: From modifiable risk factors to biomarker enrichment strategies
11. Prediction limits of a catchment hydrological model using different estimates of ETp
12. Alzheimer disease: From biomarkers to diagnosis
13. Cortical–basal ganglia imbalance in schizophrenia patients and unaffected first-degree relatives
14. On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia
15. Compliance with recommended genetic counseling for Lynch syndrome: Room for improvement
16. Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
17. Effects of aging on default mode network activity in resting state fMRI: Does the method of analysis matter?
18. FP43-TH-04 Twelve months follow-up study of fractional anisotropy changes in mild cognitive impairment and Alzheimer's disease patients compared to healthy elderly subjects
19. Enrichment of MCI and early Alzheimer's disease treatment trials using neurochemical & imaging candidate biomarkers
20. Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation
21. Multicenter assessment of reliability of cranial MRI
22. Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease
23. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
24. Task difficulty in a simultaneous face matching task modulates activity in face fusiform area
25. Cancer Risk in Hereditary Nonpolyposis Colorectal Cancer Syndrome: Later Age of Onset
26. Functional Significance and Clinical Phenotype of Nontruncating Mismatch Repair Variants of
27. Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia
28. The Founder Mutation MSH2*1906G→C Is an Important Cause of Hereditary Nonpolyposis Colorectal Cancer in the Ashkenazi Jewish Population
29. A new rapid landmark-based regional MRI segmentation method of the brain
30. Cerebrospinal fluid tau phosphorylated at threonine 231 compared to total tau in Alzheimer's disease patients, controls, and subjects at risk
31. No evidence of lateralized effects on mood after slow repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers
32. Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain
33. Progression of corpus callosum and hippocampus atrophy as independent markers of structural disease progression in Alzheimer's disease
34. Increased diagnostic accuracy in Alzheimer's disease by age-transformed hippocampal volumes
35. Repetitive transcranial magnetic stimulation in major depression — The impact of stimulation intensity on therapeutic efficacy
36. 486. Prefrontal modulation of mood and emotionally induced facial expressions: a TMS study
37. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis1Part of this work was presented in abstract form at the Twenty-Seventh Annual Meeting of the Society for Neuroscience, October 25–30, 1997, New Orleans, LA, USA.1
38. Polymorphisms in the APO E gene in gerontopsychiatric patients
39. Stimulation intensity and antidepressant action of repetitive transcranial magnetic stimulation
40. Breast C.A.R.E. Breaks: An Innovative Cancer Genetics Education Model For Health Care Professionals
41. Influence of surface texture on orange peel in aluminum
42. Frequency Variation of a Pattern-Flash Visual Stimulus during PET Differentially Activates Brain from Striate through Frontal Cortex
43. Germline BRCA1 185delAG mutations in Jewish women with breast cancer
44. 382 Total serum cholesterol and triglycerides in patients with Alzheimer's disease and healthy controls
45. 678 Elevated soluble interleukin-6-receptor-indices in Alzheimer's disease
46. Evaluation of the effects of acidic deposition on coated steel substrates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.